Abacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. Chemically, it is a synthetic carbocyclic nucleoside and is the enantiomer with 1S, 4R absolute configuration on the cyclopentene ring. In vivo, abacavir sulfate dissociates to its free base, abacavir.
Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection.[L30400] It is available in a combination product alongside [dolutegravir] and [lamivudine] for the treatment of adult and pediatric patients with HIV-1 who weigh ≥10 kg.[L41365]
Categories
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiinfectives for Systemic Use
Antiviral Agents
Antivirals for Systemic Use
Antivirals used in combination for the treatment of HIV infections
Cycloparaffins
Deoxyadenosines
Deoxyribonucleosides
Dideoxynucleosides
Direct Acting Antivirals
Drugs that are Mainly Renally Excreted
Enzyme Inhibitors
Heterocyclic Compounds, Fused-Ring
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleic Acid Synthesis Inhibitors
Nucleic Acids, Nucleotides, and Nucleosides
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
